Biotech Funding Trends: Insights from Entrepreneurs and Investors

Front Cover
John Wiley & Sons, Dec 17, 2008 - Science - 300 pages
0 Reviews
Based on interviews with successful biotech entrepreneurs and high-level investors as well as case studies, this title provides a comprehensive overview of current trends in biotech funding. In particular, it illustrates the tensions between both sides based on their different backgrounds and expectations. The book outlines the various funding opportunities for the biotech industry and identifies ways for both sides to overcome their existing prejudices in order to successfully thrive in a competitive environment.
A must-have for biotech entrepreneurs and investors, as well as invaluable supplementary reading for students aspiring to a career in the industry.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Insights from Entrepreneurs and Investors Executive Summary
1
Insights from Entrepreneurs and Investors 1 Introduction
7
Insights from Entrepreneurs and Investors 2 Methodology
27
Insights from Entrepreneurs and Investors 3 Data Analysis and Interpretation of Results
35
Insights from Entrepreneurs and Investors 4 Biotech Case Studies
87
Insights from Entrepreneurs and Investors 5 Summary and Conclusions
117
Insights from Entrepreneurs and Investors 6 Outlook and Recommendations
131
Insights from Entrepreneurs and Investors Epilogue
133
Insights from Entrepreneurs and Investors References
137
Insights from Entrepreneurs and Investors Appendix A List of Abbreviations
141
Insights from Entrepreneurs and Investors Appendix B Glossary
145
Insights from Entrepreneurs and Investors Appendix C
163
Insights from Entrepreneurs and Investors Appendix D Questionnaires
167
Insights from Entrepreneurs and Investors Index
187
Copyright

Other editions - View all

Common terms and phrases

About the author (2008)

Alexandra Carina Gruber, born in 1971 in Vienna, Austria, has been working in the pharmaceutical industry for the past 12 years, where she has held various marketing and business development positions and developed a profound expertise in the marketing and licensing of biotech and generic products. She is currently Director of Business Development & Marketing at BIOCRATES Life Sciences in Innsbruck Austria.

Bibliographic information